GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EZZ Life Science Holdings Ltd (ASX:EZZ) » Definitions » Forward PE Ratio

EZZ Life Science Holdings (ASX:EZZ) Forward PE Ratio : 0.00 (As of Jun. 08, 2024)


View and export this data going back to 2021. Start your Free Trial

What is EZZ Life Science Holdings Forward PE Ratio?

EZZ Life Science Holdings's Forward PE Ratio for today is 0.00.

EZZ Life Science Holdings's PE Ratio without NRI for today is 13.34.

EZZ Life Science Holdings's PE Ratio for today is 13.34.


EZZ Life Science Holdings Forward PE Ratio Historical Data

The historical data trend for EZZ Life Science Holdings's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EZZ Life Science Holdings Forward PE Ratio Chart

EZZ Life Science Holdings Annual Data
Trend
Forward PE Ratio

EZZ Life Science Holdings Semi-Annual Data
Forward PE Ratio

Competitive Comparison of EZZ Life Science Holdings's Forward PE Ratio

For the Biotechnology subindustry, EZZ Life Science Holdings's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EZZ Life Science Holdings's Forward PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EZZ Life Science Holdings's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where EZZ Life Science Holdings's Forward PE Ratio falls into.



EZZ Life Science Holdings Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


EZZ Life Science Holdings  (ASX:EZZ) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


EZZ Life Science Holdings Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of EZZ Life Science Holdings's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


EZZ Life Science Holdings (ASX:EZZ) Business Description

Traded in Other Exchanges
N/A
Address
104 Derby Street, Silverwater, NSW, AUS, 2128
EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.

EZZ Life Science Holdings (ASX:EZZ) Headlines

No Headlines